2024-05-14
HC Andersen – Podcast
Magnus Corfitzen, CEO and Andreas Norlin CSO present at the HC Andersen Podcast, Ascelia Pharma strong superiority of Orviglance Phase 3 study
Presentations & Articles
2024-05-07
Ascelia Pharma – Investor Update 07/05/2024
...
2024-04-16
Interview with Redeye
Magnus Corfitzen, CEO at Ascelia Pharma AB met with Redeye. In this interview, Magnus elaborated on the recent completion of the image reading phase for the SPARKLE Phase 3 re-evaluation study and provided insights into what to expect for the upcoming headline results.
2024-03-07
Penser by Carnegie- Company Day
CEO Magnus Corfitzen presents at Erik Penser by Carnegie Company Day.
2024-02-20
Penser by Carnegie- Company Status Update
CEO and Deputy CEO present at Erik Penser by Carnegie.
2024-01-04
Interview with Redeye – Progress on the SPARKLE image re-evaluation
CEO Magnus Corfitzen gives an interview at Redeye
2023-11-23
Redeye Life Science Day
Deputy CEO Julie Waras Brogren presents at Redeye Life Science Day
2023-09-22
HC Andersen – Update on re-evaluation of Sparkle headline data
Magnus Corfitzen gives an update on re-evaluation of Sparkle headline data
2023-09-12
Erik Penser Bank – Health Care Day
Deputy CEO and CCO presents at Erik Penser Health Care day.
2023-08-31
HC Andersen – Life Science Seminar
Chief Executive Officer presents at HC Andersen - Li
2023-08-23
HC Andersen – Half Year Report 2023
Chief Executive Officer presents at HC Andersen - Half Year Report 2023
2023-08-08
Ascelia Pharma – Investor Update 08/08/2023
CEO Magnus Corfitzen presents an update on the required re-evaluation on SPARKLE.
2023-06-16
Ascelia Pharma – Valencia ESGAR
Q&A with liver imaging experts. European Society of Gastrointestinal and Adbominal Radiology (ESGAR) Annual Meeting in Valencia Spain, June 13-16, 2023.
2023-05-31
ABGSC Life Science Summit
CEO Magnus Corfitzen presents at ABG Investor Day
2023-05-25
Erik Penser Bank – Company Day
Chief Executive Officer presents at Erik Pensers Company Day
2023-04-28
Redeye Orphan Drug Day
CEO Magnus Corfitzen presents at Redeye Orphan Drug Day
2023-03-30
HC Andersen – Orviglance commercial opportunity and progress towards launch
Deputy Chief Executive Officer & CCO presents at HC Andersen
2023-03-14
Ascelia Pharma – Investor Update 14/03/2023
...